Dimensional Fund Advisors LP Intra Cellular Therapies, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 83,205 shares of ITCI stock, worth $6.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,205
Previous 69,698 19.38%
Holding current value
$6.94 Million
Previous $4.77 Million 27.45%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$67.99 - $80.84 $918,340 - $1.09 Million
13,507 Added 19.38%
83,205 $6.08 Million
Q2 2024

Aug 09, 2024
SELL
$64.76 - $79.84 $5.26 Million - $6.49 Million
-81,252 Reduced 53.83%
69,698 $4.77 Million
Q1 2024

May 10, 2024
BUY
$64.37 - $75.65 $4.89 Million - $5.75 Million
76,018 Added 101.45%
150,950 $10.4 Million
Q4 2023

Feb 07, 2024
SELL
$46.37 - $73.65 $570,026 - $905,379
-12,293 Reduced 14.09%
74,932 $5.37 Million
Q3 2023

Nov 09, 2023
BUY
$52.09 - $64.1 $1.94 Million - $2.39 Million
37,235 Added 74.48%
87,225 $4.54 Million
Q2 2023

Aug 09, 2023
SELL
$54.67 - $66.44 $14.7 Million - $17.9 Million
-268,859 Reduced 84.32%
49,990 $3.17 Million
Q1 2023

May 12, 2023
SELL
$43.8 - $56.99 $8.88 Million - $11.5 Million
-202,653 Reduced 38.86%
318,849 $17.3 Million
Q4 2022

Feb 09, 2023
SELL
$44.07 - $54.45 $9.23 Million - $11.4 Million
-209,380 Reduced 28.65%
521,502 $27.6 Million
Q3 2022

Nov 10, 2022
SELL
$42.7 - $59.99 $977,232 - $1.37 Million
-22,886 Reduced 3.04%
730,882 $34 Million
Q2 2022

Aug 12, 2022
BUY
$43.0 - $65.64 $382,184 - $583,408
8,888 Added 1.19%
753,768 $43 Million
Q1 2022

May 13, 2022
SELL
$38.74 - $62.09 $1.74 Million - $2.79 Million
-44,939 Reduced 5.69%
744,880 $45.6 Million
Q4 2021

Feb 09, 2022
BUY
$35.2 - $53.42 $2.05 Million - $3.12 Million
58,340 Added 7.98%
789,819 $41.3 Million
Q3 2021

Nov 12, 2021
BUY
$28.72 - $42.49 $3.56 Million - $5.27 Million
124,045 Added 20.42%
731,479 $27.3 Million
Q2 2021

Aug 12, 2021
SELL
$29.3 - $44.5 $5.14 Million - $7.81 Million
-175,597 Reduced 22.43%
607,434 $24.8 Million
Q1 2021

May 14, 2021
SELL
$30.8 - $39.51 $12.2 Million - $15.6 Million
-394,740 Reduced 33.52%
783,031 $26.6 Million
Q4 2020

Feb 25, 2021
BUY
$23.34 - $32.22 $27.5 Million - $37.9 Million
1,177,771 New
1,177,771 $37.5 Million

Others Institutions Holding ITCI

# of Institutions
379
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email